DBV DBV Technologies SA

Monthly information regarding the total number of voting rights and  total number of shares of the Company as of February 29, 2020 and March 4, 2020

Monthly information regarding the total number of voting rights and  total number of shares of the Company as of February 29, 2020 and March 4, 2020

                     

Monthly information regarding the total number of voting rights and 

total number of shares of the Company as of February 29, 2020 and March 4, 2020

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris

ISIN Code: FR 0010417345

 



Date



 		Total number of shares Total number of voting rights
02/29/202054,588,500 



Total gross of voting rights: 54,588,500



 
 



Total net* of voting rights:  54,556,499



 



 



Date



 		Total number of shares Total number of voting rights
03/04/202054,927,187 



Total gross of voting rights: 54,927,187



 
 



Total net* of voting rights:  54,898,886



 

* Total net = total number of voting rights attached to shares – shares without voting rights



Attachment

EN
17/03/2020

Underlying

DBVDBV Technologies SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DBV Technologies SA

 PRESS RELEASE
Free
DBV DBV Technologie...

Combined General Meeting of June 11, 2025

Combined General Meeting of June 11, 2025 Châtillon, France, May 15, 2025 Combined General Meeting of June 11, 2025 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company (the “Company”), will hold its Combined General Meeting (the “General Meeting”) on June 11, 2025, at 02:00 p.m. CEST (08:00 a.m EST) at the Company’s headquarters located at IRO Building, 107 Avenue de la République, 92320 Châtillon, France. The prelimina...

May 15, 2025 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

Assemblée Générale Mixte du 11 juin 2025

Assemblée Générale Mixte du 11 juin 2025 Châtillon, France, le 15 mai 2025 Assemblée Générale Mixte du 11 juin 2025 Modalités de mise à disposition des informations et documents préparatoires à l’Assemblée Générale Mixte DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), (la « Société »), société biopharmaceutique en phase clinique, tiendra son Assemblée Générale Mixte (l’«Assemblée Générale »)  le mercredi 11 juin à 14h00 (heure de Paris), au siège social de la Société, IRO Building, 107 Avenue de la République, 92320 Châtillon. L’avis de réunion com...

May 15, 2025 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

Information regarding the total number of voting rights and  total nu...

Information regarding the total number of voting rights and  total number of shares of the Company as of April 30, 2025 Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345   Date   Total number of shares Total number of voting rights 04/30/2025   136,948,872     Total gross of voting rights: 136,948,872     Total net* of voting rights: 136,762,549   * Net total = total ...

May 6, 2025 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

Information relative au nombre total des droits de vote et d’actions ...

Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 avril 2025 Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 avril 2025 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext Paris Code ISIN : FR 0010417345 Date Nombre totald’actionscomposant le capital socialNombre totalde droits de vote30/04/2025 136.948.872Total brut des droits de vote : 136.948.872Total net* des droits de vote : 136.762.549 *Total net = nombre total de droi...

May 6, 2025 1 EN
 PRESS RELEASE
Free
DBV DBV Technologie...

DBV Technologies to Participate in the Citizens JMP Life Sciences Conf...

DBV Technologies to Participate in the Citizens JMP Life Sciences Conference Châtillon, France, May 5, 2025 DBV Technologies to Participate in the Citizens JMP Life Sciences Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the Citizens JMP Life Sciences Conference on Wednesday, May 7, 2025, at 11:00am ET, in New York, NY. A live webcast of the fireside chat can be accessed , and will also be available on the...

May 5, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch